Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms × Endocrine × Clear all

Phase

Status

Sponsor Class

OTHER 52 INDUSTRY 36 NIH 7 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 49 Gastrointestinal 23 Gynecologic 10 Breast 8 Other hematologic neoplasm 7 Genitourinary 5 Head & Neck 4 Lymphoid 3 Dermatologic 3 Classical hematology 3 CNS 3 Thoracic 2 Sarcoma 2 Other 2 Other solid neoplasm 1 Other neoplasm 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 13 Thyroid Cancer, Papillary 11 Thyroid Neoplasms 6 Pheochromocytoma 4 Paraganglioma 4 Thyroid Nodule 2 Pituitary Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Lymphatic Metastasis 2 Adrenal Gland Neoplasms 2 Wounds and Injuries 1 Vocal Cord Paralysis 1 Thyroid Diseases 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Teratoma 1 Sarcoma 1 Recurrence 1 Pituitary Diseases 1 Parkinson Disease 1 Neuroblastoma 1 Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Hypersensitivity 1 Growth Hormone-Secreting Pituitary Adenoma 1 Goiter 1 Gastro-enteropancreatic neuroendocrine tumor 1 Euthyroid Goiter 1 Disease 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07404176 2026-02-11

TENET

Tata Memorial Hospital

Phase 2 Recruiting

Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡